Quick Answer
SeaStar Medical Holding Corp reported Cash and Equivalents of $51.6 thousand for fiscal year 2021.
SeaStar Medical Holding Corp Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2021 | $51.6K | +34.3% |
| 2020 | $38.4K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2021 | $165.8K | — | -51.2% |
| June 30, 2021 | $339.7K | — | -32.5% |
| March 31, 2021 | $503.3K | — | +1211.1% |
| December 31, 2020 | $38.4K | — | — |
- SeaStar Medical Holding Corp showed an increase of +34.3% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2020–2021 period, SeaStar Medical Holding Corp’s cash and equivalents has grown by 34.3% (from $38.4 thousand to $51.6 thousand).
- The most recent figure is from SeaStar Medical Holding Corp’s fiscal year 2021 report (Form 10-K), filed with the SEC on April 6, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: